Related Experiment Video

Updated: Jun 24, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Riboregulators and metabolic disorders: getting closer towards understanding the pathogenesis of diabetes mellitus?

Subramaniam Tavintharan1, Lim Su Chi, Sum Chee Fang

  • 1. Department of Medicine, Alexandra Hospital, Singapore.

Current Molecular Medicine
|April 10, 2009
PubMed

Insights

MicroRNAs (miRNA) are small RNA molecules that play a crucial role in regulating glucose homeostasis and insulin secretion. Understanding their function offers potential new therapeutic strategies for type 2 diabetes and related metabolic disorders.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Genetics

Background:

  • Type 2 diabetes results from impaired insulin secretion and function, with metabolic syndrome and obesity as key precursors.
  • Obesity significantly contributes to insulin resistance and abnormal glucose metabolism.
  • MicroRNAs (miRNAs) are small RNA molecules regulating gene expression and cellular pathways, including those critical for glucose homeostasis.

Purpose of the Study:

  • To review the multifaceted roles of miRNAs in insulin secretion and glucose metabolism.
  • To explore the involvement of miRNAs in lipid metabolism, hypertension, and cardiovascular diseases.
  • To discuss the therapeutic potential of miRNAs in managing diabetes and related conditions.

Main Methods:

  • This review synthesizes current research on miRNA function in pancreatic islet and adipocyte biology.
  • It examines the regulatory mechanisms of miRNAs in insulin secretion, lipid metabolism, and vascular health.
  • The review discusses emerging therapeutic strategies targeting miRNAs for metabolic diseases.

Main Results:

  • Specific miRNAs are critical regulators of insulin secretion by pancreatic islet cells.
  • Adipocyte-specific miRNAs influence adipocyte differentiation and function, impacting overall glucose metabolism.
  • miRNAs are implicated in the pathophysiology of obesity, hypertension, and cardiovascular diseases, often linked to diabetes.

Conclusions:

  • Further elucidation of miRNA roles in glucose metabolism enhances understanding of pancreatic cell biology and diabetes.
  • miRNAs represent promising novel therapeutic targets for type 2 diabetes and associated metabolic and cardiovascular complications.
  • Targeting miRNAs could lead to innovative treatment strategies for metabolic disorders.

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...